Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Discounting health outcomes in economic evaluation: the ongoing debate.

Literature DB >> 15449631

Discounting health outcomes in economic evaluation: the ongoing debate.

Johan L Severens¹, Richard J Milne.

Abstract

Mesh：

Year: 2004 PMID： 15449631 DOI： 10.1111/j.1524-4733.2004.74002.x

Source DB: PubMed Journal: Value Health ISSN： 1098-3015 Impact factor: 5.725

Keyword Cloud
Cited

× No keyword cloud information.

37 in total

1. Do modern total knee replacements offer better value for money? A health economic analysis.

Authors: David F Hamilton; Nicholas D Clement; Richard Burnett; James T Patton; Mathew Moran; Colin R Howie; A H R W Simpson; Paul Gaston
Journal: Int Orthop Date: 2013-07-09 Impact factor: 3.075

2. Cost-effectiveness analysis of smoking cessation interventions using cell phones in a low-income population.

Authors: Allan T Daly; Ashish A Deshmukh; Damon J Vidrine; Alexander V Prokhorov; Summer G Frank; Patricia D Tahay; Maggie E Houchen; Scott B Cantor
Journal: Tob Control Date: 2018-06-09 Impact factor: 7.552

3. Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists.

Authors: Scott B Cantor; Ashish A Deshmukh; Nancy Stancic Luca; Graciela M Nogueras-González; Tanya Rajan; Alexander V Prokhorov
Journal: Addict Behav Date: 2015-01-14 Impact factor: 3.913

Review 4. Overview of pharmacoeconomic modelling methods.

Authors: Zanfina Ademi; Hansoo Kim; Ella Zomer; Christopher M Reid; Bruce Hollingsworth; Danny Liew
Journal: Br J Clin Pharmacol Date: 2013-04 Impact factor: 4.335

5. Cost-effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidence.

Authors: Fatih Safa Erenay; Oguzhan Alagoz; Ritesh Banerjee; Adnan Said; Robert R Cima
Journal: Cancer Date: 2016-06-01 Impact factor: 6.860

6. Cost-effectiveness of biological therapy compared with methotrexate in the treatment for rheumatoid arthritis in Colombia.

Authors: Carolina Valle-Mercado; Maria-Fernanda Cubides; Monica Parra-Torrado; Diego Rosselli
Journal: Rheumatol Int Date: 2013-08-02 Impact factor: 2.631

Discounting health outcomes in economic evaluation: the ongoing debate.

1. Do modern total knee replacements offer better value for money? A health economic analysis.

2. Cost-effectiveness analysis of smoking cessation interventions using cell phones in a low-income population.

3. Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists.

Review 4. Overview of pharmacoeconomic modelling methods.

5. Cost-effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidence.

6. Cost-effectiveness of biological therapy compared with methotrexate in the treatment for rheumatoid arthritis in Colombia.

Review 7. Challenges of Cost-Effectiveness Analyses of Novel Therapeutics for Inherited Retinal Diseases.

8. Cost-Effectiveness Analysis of Adjuvant Therapy for BRAF-Mutant Resected Stage III Melanoma in Medicare Patients.

9. What are the health costs of uranium mining? A case study of miners in Grants, New Mexico.

10. Economic evaluation of pharmacists prescribing for minor ailments in Ontario, Canada: a cost-minimization analysis.